ActivArmorTM was chosen as a finalist to pitch its waterproof, breathable, 3D printed solution for pediatric scoleosis, at the National Capital Consortium for Pediatric Device Innovation (NCC-PDI) competition, on April 30, 2019, in College Park, Maryland.
Dr. Kevin Neal, Director of Orthopedics at Nemours Childrens Hospital in Jacksonville, FL, and Diana Hall, President & Founder of ActivArmor, have proposed a study on a much improved treatment for Early Onset Scoleosis.
Early-onset scoliosis (EOS) is the development of a significant spinal curvature at a young age, prior to the adolescent growth spurt. Progressive EOS is difficult to treat, and can lead to significant problems, including increasing deformity, pain, and disability. In the worst cases, pulmonary function can be compromised, leading to thoracic insufficiency syndrome (TIS), or even death.
The current treatment requires the young patients be put into a series of plaster casts, each worn for 4-6 weeks. Each application requires the child to be put under general anesthesia, which may be a source of neurotoxicity in childrens’ developing brains. And, as these casts are not waterproof or breathable, hygiene and cleaning are a constant problem.
The proposed solution, using ActivArmor, is a progressive bracing system, similar to popular dental aligners. Using 3D modelling software, the system does not require sedation, and allows for normal daily activities, such as bathing, to continue.
“This technology has the potential to revolutionize the treatment for early onset scoliosis by limiting the number of general anesthetics and surgeries required for curve correction.” Kevin Neal, MD, Nemours Childrens